Back to results
US 2026/0248733 A1Published application
Nematocysts as natural microinjectors
OwnerJacob Beaver, Emily Breech +5inventors
InventorsJacob Beaver, Emily Breech, Vic Simons, Dave Albertson, Sarah Pruitt, Sarah Ducceschi, Megan Cruz
Life of this patent
Estimating the term…
Abstract
The present invention is directed at the formation of repurposed nematocysts which can then provide a transdermal or cutaneous delivery system.
Claims29
A method of providing nematocysts for a transdermal or cutaneous delivery comprising:
- a. providing nematocysts sourced from the genus Cassiopea or Chrysaora containing enodgenous toxins;
- b. force-firing said nematocysts and collecting said endogenous toxins;
- c. treating said nematocysts with an enzyme and inactivating said endogenous toxins.
A method of providing nematocysts for a transdermal or cutaneous delivery comprising:
- a. providing nematocysts sourced from the genus Cassiopea or Chrysaora containing enodgenous toxins;
- b. treating said nematocysts with an enzyme configured to inactivate said endogenous toxins;
- c. force-firing said nematocysts and inactivating said endogenous toxins.
A pharmaceutical composition comprising as an active ingredient, a therapeutic agent loaded into nematocysts sourced from the genus Cassiopea or Chrysaora.
Dependencies are inferred from the claim text.